Medications Development for Treatment of Opioid Use Disorder is a research paper published in Cold Spring Harbor Perspectives in Medicine (2020). On theSindex it has a DataRank of 0. It has been cited 25 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIDA NIH HHS
Grant: UG3 DA050311
NIDA NIH HHS
Grant: P30 DA033934
NIDA NIH HHS
Grant: UH3 DA041146
NIDA NIH HHS
Grant: R01 DA026946
NIDA NIH HHS
Grant: F32 DA047026
National Institutes of Health
Grant: 5F32DA047026-02
Immunoantagonist effects on opioid choice
National Institutes of Health
Grant: 5P30DA033934-09
The Central Virginia Center on Drug Abuse Research
National Institutes of Health
Grant: 5R01DA026946-02
Medications Development for Stimulant Abuse
National Institutes of Health
Grant: 5UG3DA050311-02
Mu Opioid Receptor Modulator Development to Treat Opioid Use Disorder
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals